Investigational Parkinson's disease drug (Prexton Therapeutics)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational Parkinson's disease drug (Prexton Therapeutics), covering 2016-09-28 to 2016-09-28. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects [Phase 1]